The world's leading automated proofreading software

Medical Device Recalls

Published By:

Peter Muller
< 1 minute read
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Table of Contents

Packaging, Labeling and Software – The Human Machine Interface / HMI

The majority of medical device recalls are due to labeling or software – HMI issues. TVT can help keep you from becoming a statistic.

Q1 2018
  • Medical device recalls increased 126% this past quarter, more than double last quarter and the largest quarter since at least 2005.

  • 22.7% of recalls were for software, making it the top cause for the eighth consecutive quarter.

  • The average class I units recalled in Q1 2018 alone was 186,580,917. The average number of units recalled the entire year in 2017 was a fraction of this at 511,017.

Q4 2017
  • Medical device recalls declined 9%, the lowest quarter since Q4 2011,

  • However, 25.7% of recalls were for software, making it the top cause for the seventh consecutive quarter. The 2nd reason for recalls, at 23.7%, were due to a mislabeling issue.

Q3 2017
  • The average number of medical device units involved in Class I recalls was 876,076 per quarter in 2017, nearly triple the 310,158 average in 2016. The average was 276,233 in 2015.

Q2 2017
  • 47.3% of recalls were for software or mislabeling – the same top causes as the previous two quarters.

  • 53% of recalls were distributed both domestically and internationally, the highest percentage since Q1 2016.

Try TVT and see how worry-free the labeling and software creation can be for your next medical device project.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Share this article

Peter Muller profile picture

Peter Muller

Director - Americas at Schlafender Hase

For over 25 years, Peter Muller has worked on software and process improvement projects relating to proofreading with Fortune 500 companies from various industries: Pharmaceutical, Medical Device & Consumer Goods.

Learn More

Subscribe to our blog

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Subscribe to our blog

Related Blogs

March 13, 2025

Schlafender Hase Team

Top Regulatory Challenges in Food Labeling and How to Overcome Them

Food labeling plays a crucial role in protecting consumer health by providing information relating to food sources, nutrition and safety. Accurate and informative food labeling allows consumers to make informed dietary choices. Compliance with food labeling regulations is not only a legal requirement but also impacts brand reputation.

6 minutes read

Top Regulatory Challenges in Food Labeling and How to Overcome Them

Food labeling plays a crucial role in protecting consumer health by providing information relating to food sources, nutrition and safety. Accurate and informative food labeling allows consumers to make informed dietary choices. Compliance with food labeling regulations is not only a legal requirement but also impacts brand reputation.

March 11, 2025

Schlafender Hase Team

The Future of Patient Information: A Discussion on GI 4.0® with Manuela Wiegand from Rote Liste

The way patients access critical medication information is evolving. In this expert discussion, Philipp Thomas from Schlafender Hase speaks with Manuela Wiegand, pharmacist at Rote Liste® Service GmbH, about Gebrauchsinformation 4.0 (GI 4.0®)—Germany’s move toward digital patient information leaflets.

4 minutes read

The Future of Patient Information: A Discussion on GI 4.0® with Manuela Wiegand from Rote Liste

The way patients access critical medication information is evolving. In this expert discussion, Philipp Thomas from Schlafender Hase speaks with Manuela Wiegand, pharmacist at Rote Liste® Service GmbH, about Gebrauchsinformation 4.0 (GI 4.0®)—Germany’s move toward digital patient information leaflets.

March 10, 2025

Schlafender Hase Team

Increased Focus on Promotional Compliance – Insights from OPDP and PAAB

In mid-2024, new US Food and Drug Administration (FDA) rules came into force for prescription drug advertising on television and radio. These rules are designed to promote more clarity, [1] and we can also expect future changes affecting social media influencers, especially when promoting weight loss drugs.

5 minutes read

Increased Focus on Promotional Compliance – Insights from OPDP and PAAB

In mid-2024, new US Food and Drug Administration (FDA) rules came into force for prescription drug advertising on television and radio. These rules are designed to promote more clarity, [1] and we can also expect future changes affecting social media influencers, especially when promoting weight loss drugs.